Repertoire Immune Medicines has entered into a collaboration and license agreement with Genentech to discover and develop innovative T cell-targeted immune medicines.

Singh will lead the discovery and clinical translation of peptide medicines, investing in new technologies, including data and computational science.

Antag Therapeutics, a biopharmaceutical company pioneering novel treatments for obesity, has appointed three new hires to support the Company’s next phase of growth following the recent initiation of ...

Join Mike O’Mara, COO of Cellipont Bioservices, and Marcia Blackmoore, VP of Customer Operations at L7 Informatics, for a ...

Board Certified in Endocrinology, Diabetes, and Metabolism and Internal Medicine, Dr. Caveney leads IQVIA’s Obesity, ...

Andrei Georgescu of Vivodyne discusses key advantages of its humanized drug testing platform and the impact of the FDA’s policy shift.

Suanfarma, a global company specializing in the development, production, and commercialization of active pharmaceutical ingredients (APIs) and high-value CDMO services for the health industry, has ...

Carbogen Amcis’ Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s NMPA.

The agreement is valued at over $3 billion and increases U.S. manufacturing capacity to help ensure patient access to ...

Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

Key steps for pharmaceutical companies to meet FDA’s upcoming nitrosamine testing requirements and ensure product safety.

How Ardena’s integrated services, nanomedicine expertise, and North American expansion are advancing drug development for ...